Riverside sells Diatron Group to STRATEC Biomedical
The Riverside Company has signed an agreement to sell Diatron Group (Diatron) to STRATEC Biomedical AG of Germany. Budapest-based Diatron develops, manufactures, and markets compact hematology analyzers for the human medical and veterinary markets. The transaction is expected to close near the end of this month. Riverside invested in Diatron


